Blood test for infection in immunocompromised adults
Part of Infections clinical trials.
This trial tests a blood test that looks for infection by analyzing tiny bits of DNA from microbes. It may help find infections faster in people with weakened immune systems, such as transplant recipients or those with blood cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your immune system is weakened due to a condition or treatment, like an organ transplant, blood cancer, or HIV.
- Your doctor suspects you have an infection and plans to run standard tests.
- You are willing to have a blood sample taken for the study.
- You are being evaluated in an outpatient setting (including telehealth).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to find infections (using a test called mNGS) that may be quicker and more accurate than standard tests. It is for people with blood cancers who show signs of a possible fungal infection, like fever or abnormal lung scans.
This study looks at how the immune system works in people who have—or might have—an increased risk of infections. It also enrolls their healthy blood relatives so researchers can compare immune features; results may help doctors understand who is at higher risk and why.
This study uses a blood test to find infections faster. It may help doctors choose the right treatment sooner.
This study tests a new blood testing device on healthy adults to see if it works well and is easy to use. It may help improve how blood tests are done in the future.
This trial tests a new way to take blood from patients with solid tumors or healthy volunteers, grow immune cells in a lab, and then give them back to potentially treat cancer. It may help people whose standard options have run out.
This study looks at a non-invasive blood test to detect cancer-related “signal patterns” and see how well they match different types of cancer. It may help researchers learn better ways to find or understand cancer using less invasive testing.
Hear when a new Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.